Associated Papers
Expanded spectrum of MEGF10 related myopathies: late-onset myofibrillar myopathy-like phenotype with novel variants.
Zhu B et al.
Neuromuscular Disorders : Nmd, 2026
The role of MEGF10 in myoblast fusion and hypertrophic response to overload of skeletal muscle.
Richardson L et al.
Journal of Muscle Research and Cell Motility, 2025
Phenotypic Variability of MEGF10 Variants Causing Congenital Myopathy: Report of Two Unrelated Patients from a Highly Consanguineous Population.
AlMuhaizea M et al.
Genes, 2021
Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.
Saha M et al.
Human Molecular Genetics, 2019
Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions.
Saha M et al.
Human Molecular Genetics, 2017
Japanese multiple epidermal growth factor 10 (MEGF10) myopathy with novel mutations: A phenotype-genotype correlation.
Takayama K et al.
Neuromuscular Disorders : Nmd, 2016
Megf10 Is a Receptor for C1Q That Mediates Clearance of Apoptotic Cells by Astrocytes.
Iram T et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2016
Myogenin is a positive regulator of MEGF10 expression in skeletal muscle.
Park SY et al.
Biochemical and Biophysical Research Communications, 2014
Cysteine mutations cause defective tyrosine phosphorylation in MEGF10 myopathy.
Mitsuhashi S et al.
Febs Letters, 2013
Mutations in the satellite cell gene MEGF10 cause a recessive congenital myopathy with minicores.
Boyden SE et al.
Neurogenetics, 2012
Identification of a de-novo variant of the MEGF10 gene associated with EMARDD.
Darfallah L et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia, 0
Select a paper to view details